- Home
- SNDX vs FBRT Comparison
SNDX vs FBRT Comparison
Compare SNDX & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- FBRT
- Stock Information
- Founded
- SNDX 2005
- FBRT 2012
- Country
- SNDX United States
- FBRT United States
- Employees
- SNDX N/A
- FBRT N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- FBRT Real Estate Investment Trusts
- Sector
- SNDX Health Care
- FBRT Real Estate
- Exchange
- SNDX Nasdaq
- FBRT Nasdaq
- Market Cap
- SNDX 1.1B
- FBRT 918.2M
- IPO Year
- SNDX 2016
- FBRT 1985
- Fundamental
- Price
- SNDX $14.75
- FBRT $11.28
- Analyst Decision
- SNDX Strong Buy
- FBRT Strong Buy
- Analyst Count
- SNDX 10
- FBRT 5
- Target Price
- SNDX $38.40
- FBRT $14.90
- AVG Volume (30 Days)
- SNDX 2.0M
- FBRT 398.8K
- Earning Date
- SNDX 11-04-2025
- FBRT 11-03-2025
- Dividend Yield
- SNDX N/A
- FBRT 12.55%
- EPS Growth
- SNDX N/A
- FBRT 18.52
- EPS
- SNDX N/A
- FBRT 0.98
- Revenue
- SNDX $77,933,000.00
- FBRT $207,768,000.00
- Revenue This Year
- SNDX $585.73
- FBRT $28.63
- Revenue Next Year
- SNDX $94.17
- FBRT $1.25
- P/E Ratio
- SNDX N/A
- FBRT $11.54
- Revenue Growth
- SNDX 2126.66
- FBRT 16.05
- 52 Week Low
- SNDX $8.58
- FBRT $9.79
- 52 Week High
- SNDX $22.50
- FBRT $13.74
- Technical
- Relative Strength Index (RSI)
- SNDX 47.48
- FBRT 49.13
- Support Level
- SNDX $15.71
- FBRT $11.58
- Resistance Level
- SNDX $16.50
- FBRT $11.68
- Average True Range (ATR)
- SNDX 0.81
- FBRT 0.19
- MACD
- SNDX -0.36
- FBRT -0.05
- Stochastic Oscillator
- SNDX 2.73
- FBRT 5.08
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.